Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism

被引:221
作者
ten Wolde, M
Söhne, M
Quak, E
Mac Gillavry, MR
Büller, HR
机构
[1] Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
[2] Slotervaart Hosp, Dept Internal Med, Amsterdam, Netherlands
关键词
D O I
10.1001/archinte.164.15.1685
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Echocardiographically assessed right ventricular dysfunction is increasingly used to guide more aggressive therapy in hemodynamically stable patients with acute pulmonary embolism (PE). However, the prognostic value of right ventricular dysfunction in these patients is still unclear. Methods: We systemically reviewed the literature to assess the prevalence of echocardiographic right ventricular dysfunction and the association with adverse outcomes in patients with PE who had this condition. The methodologic quality of each study was scored. Absolute risks of the outcome events were calculated for each study separately, and positive predictive values of PE-related mortality were determined for normotensive patients. Results: Seven studies were included. All had methodologic shortcomings, but they suggested an at least 2-fold increased risk of PE-related mortality in patients with right ventricular dysfunction, the prevalence of which varied from 40% to 70%. However, this seems to be less convincing in hemodynamically stable patients. The only 2 studies that allowed for an estimation of the accuracy in normotensive patients showed low positive predictive values of echo cardiographic right ventricular dysfunction for PE-related in-hospital mortality (positive predictive value, 4% and 5% in the 2 studies). Conclusion: It remains unclear whether echocardiographic right ventricular dysfunction is a prevalent and reliable predictor of adverse outcomes in hemodynamically stable patients with acute PE.
引用
收藏
页码:1685 / 1689
页数:5
相关论文
共 31 条
[1]   Thrombolysis vs heparin in the treatment of pulmonary embolism - A clinical outcome-based meta-analysis [J].
Agnelli, G ;
Becattini, C ;
Kirschstein, T .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (22) :2537-2541
[2]  
BARKER NW, 1940, P STAFF M MAYO CLIN, V15, P769
[3]  
BARRITT DW, 1960, LANCET, V1, P1309
[4]   THE CLINICAL COURSE OF PULMONARY-EMBOLISM [J].
CARSON, JL ;
KELLEY, MA ;
DUFF, A ;
WEG, JG ;
FULKERSON, WJ ;
PALEVSKY, HI ;
SCHWARTZ, JS ;
THOMPSON, BT ;
POPOVICH, J ;
HOBBINS, TE ;
SPERA, MA ;
ALAVI, A ;
TERRIN, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (19) :1240-1245
[5]  
CHERIEX EC, 1994, BRIT HEART J, V72, P52
[7]   Should echocardiography of the right ventricle help determine who receives thrombolysis for pulmonary embolism? [J].
Davidson, BL ;
Lensing, AWA .
CHEST, 2001, 120 (01) :6-8
[8]   Risk of fatal pulmonary embolism in patients with treated venous thromboembolism [J].
Douketis, JD ;
Kearon, C ;
Bates, S ;
Duku, EK ;
Ginsberg, JS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06) :458-462
[9]   Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) [J].
Goldhaber, SZ ;
Visani, L ;
De Rosa, M .
LANCET, 1999, 353 (9162) :1386-1389
[10]   ALTEPLASE VERSUS HEPARIN IN ACUTE PULMONARY-EMBOLISM - RANDOMIZED TRIAL ASSESSING RIGHT-VENTRICULAR FUNCTION AND PULMONARY PERFUSION [J].
GOLDHABER, SZ ;
HAIRE, WD ;
FELDSTEIN, ML ;
MILLER, M ;
TOLTZIS, R ;
SMITH, JL ;
DASILVA, AMT ;
COME, PC ;
LEE, RT ;
PARKER, JA ;
MOGTADER, A ;
MCDONOUGH, TJ ;
BRAUNWALD, E .
LANCET, 1993, 341 (8844) :507-511